MagForce AG, a medical device company in the field of nanomedicine focused on oncology, has announced that Vivantes Friedrichshain, Department of Neurosurgery has initiated Commercial NanoTherm Treatments for brain cancer in collaboration with Charité - Universitätsmedizin Berlin, Clinic for Radiation Therapy who is participating also in the ongoing post-marketing study.
NanoTherm Therapy is a brain tumour therapy that has CE certifications for the treatment of all brain cancers. It is used to enhance the effect of conventional radiation therapy. NanoTherm Therapy is applied by heating of the tumour from inside using nanoparticles, which are directly positioned neurosurgically into the tumour and are subsequently activated contactless to the patient by an alternating magnetic field. Preferentially, NanoTherm was successfully applied to the most malignant brain tumour which is Glioblastoma multiforme.